Literature DB >> 19427693

NK cells detect changes in adaptive immunity within mouse decidua from gestation day eight.

K Hatta1, M J van den Heuvel, B A Croy.   

Abstract

Viable human CD56+ CD16- peripheral blood Natural Killer (NK) cells show specific in vitro binding under shear forces to ligands expressed by endothelial cells in cryostat sections of gestation day (gd)7 mouse decidua basalis. In serial assays, numbers of cells adhering to gd7 tissue are constant for men but have cyclical variation for fertile women, suggesting a brief gain in functional decidual homing potential of this NK cell subset during the menstrual cycle. Regardless of gender, numbers of adhering cells from an individual donor, increase dramatically when the substrate is decidua basalis from a later gestational timepoint. Here, we report that human blood CD56+ CD16- NK cells which adhere as single cells over gd7 decidua basalis, adhere as large clusters over gd8 and gd9 tissues, suggestive of antigen recognition and lymphocyte activation. We asked which cells within mouse decidua basalis trigger this response in CD56+ CD16- cells. Using decidua from mice transgenic for myeloid dendritic cell (mDC) expression of enhanced yellow fluorescent protein (eYFP), we found cluster formation was independent of mDC contact. Use of decidua from alymphoid mice showed clustering behavior required substrate lymphocytes. By use of decidua containing NK cells but lacking T and B cells, decidual T and/or B lymphocytes were identified as the cells altered after gd7 in a manner that activates CD56+ CD16- cell clustering. This timepoint is just prior to mouse spiral arterial modification and its detection by these indicator cells implicates adaptive, decidual immune responses in the regulation of NK cell function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427693      PMCID: PMC2949413          DOI: 10.1016/j.placenta.2009.04.001

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  41 in total

1.  Periovulatory increases in tissue homing potential of circulating CD56(bright) cells are associated with fertile menstrual cycles.

Authors:  Marianne J van den Heuvel; Julie Horrocks; Siamak Bashar; Kota Hatta; Suzanne Burke; Sharon S Evans; B Anne Croy; Francis R Tekpetey
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958

Review 2.  Close encounters of the first and second kind: T-DC and T-B interactions in the lymph node.

Authors:  Michael D Cahalan; Ian Parker
Journal:  Semin Immunol       Date:  2005-11-02       Impact factor: 11.130

Review 3.  Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones.

Authors:  B Anne Croy; Marianne J van den Heuvel; Angela M Borzychowski; Chandrakant Tayade
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

4.  Cells with haematopoietic stem cell phenotype in adult human endometrium: relevance to infertility?

Authors:  L Lynch; L Golden-Mason; M Eogan; C O'Herlihy; Cliona O'Farrelly
Journal:  Hum Reprod       Date:  2007-01-05       Impact factor: 6.918

5.  CD56+ cells are recruited to the uterus in two waves: at ovulation and during the first 2 weeks after missed menses.

Authors:  Marianne J van den Heuvel; Kota Hatta; Crystal G Peralta; Victor K Han; David A Clark
Journal:  Am J Reprod Immunol       Date:  2007-11-21       Impact factor: 3.886

6.  Central role of interleukin-15 in postovulatory recruitment of peripheral blood CD16(-) natural killer cells into human endometrium.

Authors:  Kotaro Kitaya; Takeshi Yamaguchi; Hideo Honjo
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

7.  Pathways participating in activation of mouse uterine natural killer cells during pregnancy.

Authors:  Xuemei Xie; Hong He; Marco Colonna; Tsukasa Seya; Toshiyuki Takai; B Anne Croy
Journal:  Biol Reprod       Date:  2005-05-04       Impact factor: 4.285

8.  Aberrant endometrial features of pregnancy in diabetic NOD mice.

Authors:  Suzanne D Burke; Hongmei Dong; Aleah D Hazan; B Anne Croy
Journal:  Diabetes       Date:  2007-09-07       Impact factor: 9.461

9.  Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.

Authors:  Marianne J van den Heuvel; Crystal G Peralta; Kota Hatta; Victor K Han; David A Clark
Journal:  Am J Reprod Immunol       Date:  2007-11       Impact factor: 3.886

10.  Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy.

Authors:  Claudia Carlino; Helena Stabile; Stefania Morrone; Roberta Bulla; Alessandra Soriani; Chiara Agostinis; Fleur Bossi; Carlo Mocci; Filippo Sarazani; Francesco Tedesco; Angela Santoni; Angela Gismondi
Journal:  Blood       Date:  2008-01-10       Impact factor: 22.113

View more
  4 in total

1.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

2.  Circulating CD56+ cells of diabetic women show deviated homing potential for specific tissues during and following pregnancy.

Authors:  A V C Seaward; S D Burke; H Ramshaw; G N Smith; B A Croy
Journal:  Hum Reprod       Date:  2011-04-12       Impact factor: 6.918

3.  Altered DNA methylation in leukocytes with trisomy 21.

Authors:  Kristi Kerkel; Nicole Schupf; Kota Hatta; Deborah Pang; Martha Salas; Alexander Kratz; Mark Minden; Vundavalli Murty; Warren B Zigman; Richard P Mayeux; Edmund C Jenkins; Ali Torkamani; Nicholas J Schork; Wayne Silverman; B Anne Croy; Benjamin Tycko
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

4.  Imaging of vascular development in early mouse decidua and its association with leukocytes and trophoblasts.

Authors:  B Anne Croy; Zhilin Chen; Alexander P Hofmann; Edith M Lord; Abigail L Sedlacek; Scott A Gerber
Journal:  Biol Reprod       Date:  2012-11-29       Impact factor: 4.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.